JPMORGAN CHASE & CO

Position in ACRV — Acrivon Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in ACRV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,335

+$450 QoQ

Shares Held

751

+17.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#36

of 46 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. ACRV ranks #359 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,335	751	+17.7%	Shares	Defined	2026-08-12
2026-03-31	$885	638	-96.2%	Shares	Defined	2026-05-13
2025-12-31	$40,641	16,864	+868.6%	Shares	Defined	2026-02-11
2025-09-30	$3,151	1,741	+22.8%	Shares	Defined	2025-11-07
2025-06-30	$1,687	1,418	-83.3%	Shares	Defined	2025-08-12
2025-03-31	$17,211	8,479	-67.1%	Shares	Defined	2025-05-12
2024-12-31	$155,369	25,809	-24.1%	Shares	Defined	2025-02-12
2024-09-30	$237,937	33,991	+548.3%	Shares	Defined	2024-12-26
2024-06-30	$30,409	5,243	+5.7%	Shares	Defined	2024-12-26
2024-03-31	$35,456	4,959	-85.1%	Shares	Defined	2024-12-26
2023-12-31	$164,047	33,343	+25.5%	Shares	Defined	2024-12-26
2023-09-30	$254,028	26,572	+283.6%	Shares	Defined	2023-11-14
2023-06-30	$89,773	6,927	+4.5%	Shares	Defined	2023-08-11
2023-03-31	$84,134	6,630	—	Shares	Defined	2023-05-18
No filing history on record for this holder in this stock.